PubMed

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

Ann Intern Med. 2001 Feb 6;134(3):191-202.PMID: 11177331 [PubMed - indexed for MEDLINE]Related articlesFree article

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

Ann Intern Med. 2004 Jun 1;140(11):867-73.PMID: 15172900 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators.

JAMA. 2006 Aug 23;296(8):935-42.PMID: 16926353 [PubMed - indexed for MEDLINE]Related articlesFree article

Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.

Couturaud F, Julian JA, Kearon C.

Thromb Haemost. 2001 Oct;86(4):980-4.PMID: 11686355 [PubMed - indexed for MEDLINE]Related articles

Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.

Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group.

J Thromb Thrombolysis. 2005 Jun;19(3):173-81.PMID: 16082604 [PubMed - indexed for MEDLINE]Related articles

A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.

Bergmann JF, Neuhart E.

Thromb Haemost. 1996 Oct;76(4):529-34.PMID: 8902991 [PubMed - indexed for MEDLINE]Related articles

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.

Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV; CORTES Investigators. Clivarin: Assessment of Regression of Thrombosis, Efficacy, and Safety.

N Engl J Med. 2001 Mar 1;344(9):626-31.PMID: 11228276 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.

de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, Hart HC, Sixma JJ, Nieuwenhuis HK.

Ann Intern Med. 1995 Jul 1;123(1):1-9.PMID: 7539233 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.

J Bone Joint Surg Am. 1994 Jan;76(1):3-14. Erratum in: J Bone Joint Surg Am 1994 Mar;76(3):4741. PMID: 8288662 [PubMed - indexed for MEDLINE]Related articles

Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury.

Hebbeler SL, Marciniak CM, Crandall S, Chen D, Nussbaum S, Mendelewski S.

J Spinal Cord Med. 2004;27(3):236-40.PMID: 15478526 [PubMed - indexed for MEDLINE]Related articles

Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.

Riess H, Koppenhagen K, Tolle A, Kemkes-Matthes B, Gräve M, Patek F, Drexler M, Siemens HJ, Harenberg J, Weidinger G, Brom J, Haas S; TH-4 Study Group.

Thromb Haemost. 2003 Aug;90(2):252-9.PMID: 12888872 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

JAMA. 2005 Feb 9;293(6):681-9.PMID: 15701909 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.

Fitzgerald RH Jr, Spiro TE, Trowbridge AA, Gardiner GA Jr, Whitsett TL, O'Connell MB, Ohar JA, Young TR; Enoxaparin Clinical Trial Group.

J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6.PMID: 11407799 [PubMed - indexed for MEDLINE]Related articles

Cost for inpatient care of venous thrombosis: a trial of enoxaparin vs standard heparin.

de Lissovoy G, Yusen RD, Spiro TE, Krupski WC, Champion AH, Sorensen SV.

Arch Intern Med. 2000 Nov 13;160(20):3160-5.PMID: 11074747 [PubMed - indexed for MEDLINE]Related articlesFree article

Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.

Prandoni P, Carnovali M, Marchiori A; Galilei Investigators.

Arch Intern Med. 2004 May 24;164(10):1077-83.PMID: 15159264 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Quinlan DJ, McQuillan A, Eikelboom JW.

Ann Intern Med. 2004 Feb 3;140(3):175-83.PMID: 14757615 [PubMed - indexed for MEDLINE]Related articlesFree article

Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.

Gonzalez-Fajardo JA, Arreba E, Castrodeza J, Perez JL, Fernandez L, Agundez I, Mateo AM, Carrera S, Gutiérrez V, Vaquero C.

J Vasc Surg. 1999 Aug;30(2):283-92.PMID: 10436448 [PubMed - indexed for MEDLINE]Related articles

Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.

Wellington K, McClellan K, Jarvis B.

Drugs. 2001;61(8):1185-209. Review.PMID: 11465877 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.

Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, Tremaine MD.

Ann Intern Med. 1994 Jul 15;121(2):81-9.PMID: 8017740 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.

Hull RD, Raskob GE, Brant RF, Pineo GF, Elliott G, Stein PD, Gottschalk A, Valentine KA, Mah AF.

Arch Intern Med. 2000 Jan 24;160(2):229-36.PMID: 10647762 [PubMed - indexed for MEDLINE]Related articlesFree article